Paediatric Respiratory Reviews
Volume 7, Issue 1 , Pages 15-20 , March 2006

Investigation and management of suppurative cough in pre-school children

References 

  1. Kliegman R, Behrman R. Infectious diseases. In:  Behrman RE,  Kliegman RM,  Nelson WE,  Vaughan VC editor. Textbook of Pediatrics. 14th edn. Philadelphia: WB Saunders Company; 1992;
  2. Morice AH. Epidemiology of cough. Pulmon Pharmacol Ther. 2002;15:253–259
  3. Kogan MD, Pappas G, Yu SM, Kotelchuck M. Over-the-counter medication use among preschool-age children. JAMA. 1994;272:1025–1030
  4. Leonardi GS, Houthuijs D, Nikiforov B, et al. Respiratory symptoms, bronchitis and asthma in children of Central and Eastern Europe. Eur Respir J. 2002;20:890–898
  5. Spee-van der Wekke J, Meulmeester JF, Radder JJ, Verloove-Vanhorick SP. School absence and treatment in school children with respiratory symptoms in The Netherlands: data from the Child Health Monitoring System. J Epidemiol Commun Health. 1998;52:359–363
  6. Hay AD, Wilson AD. The natural history of acute cough in children aged 0 to 4 years in primary care: a systematic review. Br J Gen Pract. 2002;52:401–409
  7. Boulet LP, Becker A, Berube D, Beveridge R, Ernst P. Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. Can Med Assoc J. 1999;161(Suppl):S1–S61
  8. Nikolaizik W, Warner J. Aetiology of chronic suppurative lung disease. Arch Dis Child. 1994;70:141–142
  9. Seaton A, Seaton D, Leitch AG. Crofton and Douglas's Respiratory Diseases. 5th edn. Oxford: Blackwell Science; 2000;
  10. Maxwell GM. Chronic chest disease in Australian aboriginal children. Arch Dis Child. 1972;47:897–901
  11. Sayajakanagas O, Keisteinen T, Tuuponen TO. Evaluation of incidence and age distribution of bronchiectasis from the Finish Hospital Discharge Register. Cent Eur J Pub Health. 1998;6:235–237
  12. Twiss J, Metcalfe R, Edwards E, Bynres . New Zealand national incidence of bronchiectasis ‘too high’ for a developed country. Arch Dis Child. 2005;90:737–740
  13. Chang A, Grimwood K, Mulholland E. Bronchiectasis in indigenous children in remote Australian communities. Med J Aust. 2002;177:200–204
  14. Gibson LF, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine iontophoreses. Pediatrics. 1959;23:545
  15. Bush A, Wallis C. Time to think again: cystic fibrosis is not an ‘all or none’ disease. Pediatr Pulmonol. 2000;30:139–144
  16. Bruwer A, Clagett OT, Mcdonald J. Anomalous arteries to the lung associated with congenital pulmonary abnormality. J Thorac Surg. 1950;19:957–959
  17. Woodring JH, Howard RS, Rehm SR. Congenital tracheomeglay (Mounier Kuhn syndrome): a report of 10 cases and review of the literature. J Thorac Imaging. 1991;6:1–10
  18. Rao K, Amrolia PJ, Jones A, et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood. 2005;105:879–885
  19. Afzelius BA. A human syndrome caused by immotile cilia. Science. 1976;193:317–319
  20. Sturgess JM, Chao J, Turner JAP. Genetic heterogeneity among dynein deficient cilia. Am Rev Respir Dis. 1982;126:302–306
  21. Sturgess JM, Chao J, Turner JAP. Transposition of ciliary microtubules: another cause of impaired ciliary motility. N Engl J Med. 1980;303:318
  22. Turner JAP, Corkey CWB, Lee JYC. Clinical expressions of immotile cilia syndrome. Pediatrics. 1981;67:805
  23. Steen KH, Zimmermann T. Tracheobronchial foreign body aspiration in children. Report of over 94 patients. Monatsschrift Kinderheilkunde. Organ der Deutschen Gesellschaft fur Kinderheilkunde. 1989;137:138–143
  24. Ulloa-Gutierrez R, Avila-Aguero ML. Varicella associated with Staphylococcus aureus purulent pericarditis. Pediatr Infect Dis J. 2003;22:935–936
  25. Preblud SR, Orenstein W, Bart KJ. Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis. 1984;3:505
  26. Kabra SK, Alok A, Kapil A, et al. Can throat swab after physiotherapy replace sputum for identification of microbial pathogens in children with cystic fibrosis?. Ind J Pediatr. 2004;71:21–23
  27. Equi AC, Pike SE, Davies J, Bush A. Use of cough swabs in a cystic fibrosis clinic. Arch Dis Child. 2001;85:438–439
  28. Isaacs D, Mellis CM. Tuberculosis in children in Australia: strategies for control. Paediatric Special Interest Group of the Australasian Society for Infectious Diseases and the Australasian Paediatric Respiratory Group. Med J Aust. 1998;168:121–124
  29. Kartagnener M. Zur pathogenese der bronkiectasien: bronkiectasien bei situs viscerum inversus. Beitr Klin Tuberk. 1933;82:489
  30. Eliasson R, Mossberg B, Camner P, Afzelius BA. The immotile cilia syndrome. N Engl J Med. 1977;297:1
  31. Ribet M, Pruvot FR, Dubos JP. Congenital cystic adenomatoids malformation of the lung. Eur J Cardiothorac Surg. 1990;4:403–405
  32. Davenport M, Warne SA, Cacciaguerra S, Patel S, Greenough A, Nicolaides K. Current outcome of antenally diagnosed cystic lung disease. J Pediatr Surg. 2004;39:549–556
  33. Chang AB, Boyce NC, Masters IB, Torzillo PJ, Masel JP. Bronchoscopic findings in children with non-cystic fibrosis chronic suppurative lung disease. Thorax. 2002;57:935–938
  34. De Longh RU, Rutland J. Ciliary defects in healthy subjects, bronchiectasis and primary ciliary dyskinesia. Am J Respir Crit Care Med. 1995;151:1559
  35. Karadag B, James AJ, Gultekin E, Wilson NM, Bush A. Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia. Eur Respir J. 1999;13:1402–1405
  36. Kolbe J, Wells A, Ram FS. Inhaled steroids for bronchiectasis. Cochrane Database Syst Rev 2. Oxford: Update Software, 2000.
  37. Lasserson T, Holt K, Greenstone M. Oral steroids for bronchiectasis (stable and acute exacerbations) (Cochrane Review). Cochrane Database Syst Rev 4. Oxford: Update Software, 2001; CD002162.
  38. Crockett AJ, Cranston JM, Latimer KM, Alpers JH. Mucolytics for bronchiectasis. Cochrane Database Syst Rev 2. Oxford: Update Software, 2000.
  39. Lasserson T, Holt K, Evans D, Greenstone M. Anticholinergic therapy for bronchiectasis (Cochrane Review). Cochrane Database Syst Rev 4. Oxford: Update Software, 2001; CD002163.
  40. Sheikh A, Nolan D, Greenstone M. Long-acting beta-2-agonists for bronchiectasis (Cochrane Review). Cochrane Database Syst Rev 4. Oxford: Update Software, 2001; CD002155.
  41. Steele K, Greenstone M, Lasserson JA. Oral methyl-xanthines for bronchiectasis (Cochrane Review). Cochrane Database Syst Rev 1. Oxford: Update Software, 2001; CD002734.
  42. Corless JA, Warburton CJ. Surgery vs non-surgical treatment for bronchiectasis. Cochrane Database Syst Rev 4. Oxford: Update Software, 2000.
  43. Phillips GE, Thomas S, Heather S, Bush A. Airway response of children with primary ciliary dyskinesia to exercise and beta2-agonist challenge. Eur Respir J. 1998;11:1389–1391
  44. Wills P, Greenstone M. Inhaled hyperosmolar agents for bronchiectasis (Cochrane Review). Cochrane Database Syst Rev 2. Oxford: Update Software, 2001; CD002996.
  45. Jones AP, Rowe BH. Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis. Cochrane Database Syst Rev 2. Oxford: Update Software, 2000.
  46. Gremmo ML, Guenza MC. Positive expiratory pressure in the physiotherapeutic management of primary ciliary dyskinesia in paediatric age. Monaldi Arch Chest Dis. 1999;54:255–257
  47. Pedersen M, Stafanger G. Bronchopulmonary symptoms in primary ciliary dyskinesia. A clinical study of 27 patients. Eur J Respir Dis. 1983;127:118–122
  48. Corless JA, Warburton CJ. Surgery vs non-surgical treatment for bronchiectasis. Cochrane Database Syst Rev 4. Oxford: Update Software, 2000.

PII: S1526-0542(05)00118-1

doi: 10.1016/j.prrv.2005.11.001

Paediatric Respiratory Reviews
Volume 7, Issue 1 , Pages 15-20 , March 2006

Article Tools